What is ScitoVation?
ScitoVation operates as a specialized Contract Research Organization (CRO) dedicated to the rigorous evaluation of safety and efficacy for pharmaceuticals, chemicals, and consumer goods. The company distinguishes itself through the application of innovative New Approach Methods (NAMs), which move beyond traditional testing paradigms to provide more accurate, human-relevant data. By integrating sophisticated tools such as Physiologically Based Pharmacokinetic (PBPK) modeling and high-throughput toxicogenomic studies, ScitoVation enables its clients to navigate complex regulatory environments with greater efficiency. Their service model is designed to reduce the time-to-market for lead compounds while simultaneously lowering research expenditures, making them an indispensable partner for global chemical manufacturers and pharmaceutical innovators seeking to optimize their product development lifecycles.
How much funding has ScitoVation raised?
ScitoVation has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ScitoVation
PPP
Public-Private Partnership
What's next for ScitoVation?
With the successful closure of this late-stage financing, ScitoVation is poised to scale its operational capacity and expand its suite of predictive safety solutions. The strategic roadmap likely involves deepening investments in computational toxicology and enhancing the scalability of their proprietary NAM platforms to meet the growing demand for animal-free testing alternatives. As regulatory bodies worldwide increasingly favor non-animal testing methodologies, ScitoVation is strategically aligned to capture significant market share. The firm will likely focus on broadening its client base across the cosmetics and food ingredient sectors, where the pressure for rapid, cost-effective safety validation is intensifying. This capital injection provides the necessary runway to refine their technological infrastructure, ensuring they remain at the vanguard of the predictive science industry while maintaining high-fidelity research standards.
See full ScitoVation company page
